Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity
2025 · Cancer Cell · 36 citations
https://doi.org/10.1016/j.ccell.2025.01.004
J
Julian Kött
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
252
Citations
9
h-index
8
i10-index
Julian Kött is an academic researcher from Universität Hamburg. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & Cutaneous Melanoma Detection and Management. The author has an h-index of 9, co-authored 58 publications.
ORCID: 0000-0003-2073-3909Papers by this author
worksEmerging precision diagnostics in advanced cutaneous squamous cell carcinoma
2022 · npj Precision Oncology · 17 citations
https://doi.org/10.1038/s41698-022-00261-z
Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma
2024 · EMBO Molecular Medicine · 17 citations
https://doi.org/10.1038/s44321-024-00082-6
Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy – A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg
2024 · European Journal of Cancer · 10 citations
https://doi.org/10.1016/j.ejca.2024.115159
In-depth assessment of BRAF, NRAS, KRAS, EGFR, and PIK3CA mutations on cell-free DNA in the blood of melanoma patients receiving immune checkpoint inhibition
2025 · Journal of Experimental & Clinical Cancer Research · 6 citations
https://doi.org/10.1186/s13046-025-03457-w
Evaluation of S100A8/A9 and neutrophils as prognostic markers in metastatic melanoma patients under immune-checkpoint inhibition
2024 · Translational Oncology · 5 citations
https://doi.org/10.1016/j.tranon.2024.102224
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat